- Home
- PRME vs DGICB Comparison
PRME vs DGICB Comparison
Compare PRME & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- DGICB
- Stock Information
- Founded
- PRME 2019
- DGICB 1986
- Country
- PRME United States
- DGICB United States
- Employees
- PRME N/A
- DGICB N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- DGICB Property-Casualty Insurers
- Sector
- PRME Health Care
- DGICB Finance
- Exchange
- PRME Nasdaq
- DGICB Nasdaq
- Market Cap
- PRME 693.5M
- DGICB 562.0M
- IPO Year
- PRME 2022
- DGICB N/A
- Fundamental
- Price
- PRME $5.10
- DGICB $15.50
- Analyst Decision
- PRME Buy
- DGICB
- Analyst Count
- PRME 6
- DGICB 0
- Target Price
- PRME $8.88
- DGICB N/A
- AVG Volume (30 Days)
- PRME 4.0M
- DGICB 1.1K
- Earning Date
- PRME 11-11-2025
- DGICB 10-30-2025
- Dividend Yield
- PRME N/A
- DGICB 4.10%
- EPS Growth
- PRME N/A
- DGICB 965.80
- EPS
- PRME N/A
- DGICB 2.34
- Revenue
- PRME $4,961,000.00
- DGICB $993,644,532.00
- Revenue This Year
- PRME $179.58
- DGICB $2.26
- Revenue Next Year
- PRME N/A
- DGICB $3.46
- P/E Ratio
- PRME N/A
- DGICB $8.15
- Revenue Growth
- PRME 739.42
- DGICB 3.36
- 52 Week Low
- PRME $1.11
- DGICB $12.61
- 52 Week High
- PRME $6.94
- DGICB $20.46
- Technical
- Relative Strength Index (RSI)
- PRME 46.40
- DGICB 50.26
- Support Level
- PRME $5.39
- DGICB $14.87
- Resistance Level
- PRME $6.30
- DGICB $15.87
- Average True Range (ATR)
- PRME 0.66
- DGICB 0.25
- MACD
- PRME -0.15
- DGICB 0.13
- Stochastic Oscillator
- PRME 1.60
- DGICB 38.15
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.